163 related articles for article (PubMed ID: 37841195)
1. High-Titer Recombinant Adenovirus 26 Vector GMP Manufacturing in HEK 293 Cells with a Stirred Single-Use Bioreactor for COVID-19 Vaccination Purposes.
Sedighikamal H; Sattarzadeh A; Karimi Mostofi R; Dinarvand B; Nazarpour M
ACS Omega; 2023 Oct; 8(40):36720-36728. PubMed ID: 37841195
[TBL] [Abstract][Full Text] [Related]
2. The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process.
Nie J; Sun Y; Feng K; Huang L; Li Y; Bai Z
Vaccine; 2022 Mar; 40(13):2036-2043. PubMed ID: 35216843
[TBL] [Abstract][Full Text] [Related]
3. A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates.
Liu H; Liu XM; Li SC; Wu BC; Ye LL; Wang QW; Chen ZL
J Biosci Bioeng; 2009 May; 107(5):524-9. PubMed ID: 19393552
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor.
Offersgaard A; Duarte Hernandez CR; Pihl AF; Costa R; Venkatesan NP; Lin X; Van Pham L; Feng S; Fahnøe U; Scheel TKH; Ramirez S; Reichl U; Bukh J; Genzel Y; Gottwein JM
Vaccines (Basel); 2021 Jun; 9(7):. PubMed ID: 34209694
[TBL] [Abstract][Full Text] [Related]
5. Optimization of an adenovirus-vectored zoster vaccine production process with chemically defined medium and a perfusion system.
Nie J; Sun Y; Ren H; Huang L; Feng K; Li Y; Bai Z
Biotechnol Lett; 2022 Nov; 44(11):1347-1358. PubMed ID: 36183022
[TBL] [Abstract][Full Text] [Related]
6. Improving adeno-associated vector yield in high density insect cell cultures.
Mena JA; Aucoin MG; Montes J; Chahal PS; Kamen AA
J Gene Med; 2010 Feb; 12(2):157-67. PubMed ID: 20101623
[TBL] [Abstract][Full Text] [Related]
7. Development of an Optimized Process for Functional Recombinant SARS-CoV-2 Spike S1 Receptor-Binding Domain Protein Produced in the Baculovirus Expression Vector System.
Boumaiza M; Chaabene A; Akrouti I; Ben Zakour M; Askri H; Salhi S; Ben Hamouda W; Marzouki S; Benabdessalem C; Ben Ahmed M; Trabelsi K; Rourou S
Trop Med Infect Dis; 2023 Nov; 8(11):. PubMed ID: 37999620
[TBL] [Abstract][Full Text] [Related]
8. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
[TBL] [Abstract][Full Text] [Related]
9. Growth kinetics of an Indian isolate of highly pathogenic porcine reproductive and respiratory syndrome virus in MARC-145 cells.
Kombiah S; Senthilkumar D; Kumar M; Sivasankar P; Singh VP; Rajukumar K
Virusdisease; 2022 Jun; 33(2):208-214. PubMed ID: 35991703
[TBL] [Abstract][Full Text] [Related]
10. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
Rourou S; van der Ark A; van der Velden T; Kallel H
Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
[TBL] [Abstract][Full Text] [Related]
11. Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures.
Fulber JPC; Farnós O; Kiesslich S; Yang Z; Dash S; Susta L; Wootton SK; Kamen AA
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835266
[TBL] [Abstract][Full Text] [Related]
12. Development of a perfusion process for serum-free adenovirus vector herpes zoster vaccine production.
Sun Y; Huang L; Nie J; Feng K; Liu Y; Bai Z
AMB Express; 2022 May; 12(1):58. PubMed ID: 35567723
[TBL] [Abstract][Full Text] [Related]
13. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
[TBL] [Abstract][Full Text] [Related]
14. Rational scale-up of a baculovirus-insect cell batch process based on medium nutritional depth.
Yang JD; Gecik P; Collins A; Czarnecki S; Hsu HH; Lasdun A; Sundaram R; Muthukumar G; Silberklang M
Biotechnol Bioeng; 1996 Dec; 52(6):696-706. PubMed ID: 18629948
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
Logunov DY; Dolzhikova IV; Zubkova OV; Tukhvatullin AI; Shcheblyakov DV; Dzharullaeva AS; Grousova DM; Erokhova AS; Kovyrshina AV; Botikov AG; Izhaeva FM; Popova O; Ozharovskaya TA; Esmagambetov IB; Favorskaya IA; Zrelkin DI; Voronina DV; Shcherbinin DN; Semikhin AS; Simakova YV; Tokarskaya EA; Lubenets NL; Egorova DA; Shmarov MM; Nikitenko NA; Morozova LF; Smolyarchuk EA; Kryukov EV; Babira VF; Borisevich SV; Naroditsky BS; Gintsburg AL
Lancet; 2020 Sep; 396(10255):887-897. PubMed ID: 32896291
[TBL] [Abstract][Full Text] [Related]
16. Performance Comparison of Recombinant Baculovirus and Rabies Virus-like Particles production Using Two Culture Platforms.
Guardalini LGO; Cavalcante PEDS; Leme J; Mello RG; Bernardino TC; Jared SGS; Antoniazzi MM; Astray RM; Tonso A; Fernández Núñez EG; Jorge SAC
Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679884
[TBL] [Abstract][Full Text] [Related]
17. Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor.
Arifin MA; Mel M; Abdul Karim MI; Ideris A
J Biomed Biotechnol; 2010; 2010():586363. PubMed ID: 20625497
[TBL] [Abstract][Full Text] [Related]
18. Development and scale-up of rVSV-SARS-CoV-2 vaccine process using single use bioreactor.
Ton C; Stabile V; Carey E; Maraikar A; Whitmer T; Marrone S; Afanador NL; Zabrodin I; Manomohan G; Whiteman M; Hofmann C
Biotechnol Rep (Amst); 2023 Mar; 37():e00782. PubMed ID: 36687766
[TBL] [Abstract][Full Text] [Related]
19. Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor.
Trabelsi K; Majoul S; Rourou S; Kallel H
Appl Microbiol Biotechnol; 2012 Feb; 93(3):1031-40. PubMed ID: 21935589
[TBL] [Abstract][Full Text] [Related]
20. Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity.
Maranga L; Cunha A; Clemente J; Cruz P; Carrondo MJ
J Biotechnol; 2004 Jan; 107(1):55-64. PubMed ID: 14687971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
